Amarin (AMRN) Could See Action on Takeover Report
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Amarin Corporation plc (NASDAQ: AMRN) could see action Wednesday following reports from the UK's Daily Mail that AstraZeneca (NYSE: AZN) plans to launch a bid for the company.
While certainly to create a stir, the article appear very speculative in nature. That, and the fact that takeover speculation has been surrounding the name for months could keep a lid on things. Also, shares of Amarin rose 4.7 percent Tuesday on - you guessed it - takeover speculation.
While certainly to create a stir, the article appear very speculative in nature. That, and the fact that takeover speculation has been surrounding the name for months could keep a lid on things. Also, shares of Amarin rose 4.7 percent Tuesday on - you guessed it - takeover speculation.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amarin presents new REDUCE-IT data at ESC Congress 2026
- Putin, Xi, Trump may hold trilateral talks at APEC summit - Russia's Vesti
- Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
